1 Min Read
Jan 18 (Reuters) - Prometic Life Sciences Inc
* European Commission grants orphan drug designation to Prometic’s PBI-4050 drug for the treatment of Alström Syndrome Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.